// App-Quantinova.ai

OP0186 : HYDROXYCHLOROQUINE IN PATIENTS WITH INFLAMMATORY AND EROSIVE OSTEOARTHRITIS OF THE HANDS: RESULTS OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED, MULTI-CENTRE, INVESTIGATOR-INITIATED TRIAL (OA TREAT)

Researchers

Presenter

  • C. Kedor

Principal Investigators

  • J. Detert

  • R. Rau

  • S. Wassenberg

  • J. Listing

  • P. Klaus

  • T. Braun

  • W. Hermann

  • S. Weiner

  • M. Bohl-Bhler

  • F. Buttgereit

  • G. R. Burmester

Medical Centers

  • Charite Univsmedizin Berlin, Berlin, Germany

  • Rheuma-Templin, Templin, Germany

  • Rheuma Zentrum Ratingen, Ratingen, Germany

  • Deutsches Rheumaforschungszentrum, Berlin, Germany

  • Pfizer Pharma GmbH, Berlin, Germany

  • Kerckhoff-Klinik, Bad Nauheim, Abteilung Rheumatologie, Bad Nauheim, Germany

  • Krankenhaus der Barmherzigen Brueder, Trier, Trier, Germany

  • Rheumahaus, Potsdam, Germany

Locations

  • Germany

Companies

  • PharmAbcine Inc.

Study Components

Therapeutic Area

  • Musculoskeletal

Disease

  • Erosive Disease

  • Osteoarthritis

Biomarkers

  • Albumin/creatinine

Drug/Treatment

  • Hydroxychloroquine

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

  • Double Blind/Blinded

  • Multicenteric

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • Amgen

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved